Belmaker Rh

1.0k total citations
40 papers, 712 citations indexed

About

Belmaker Rh is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Belmaker Rh has authored 40 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 6 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Belmaker Rh's work include Bipolar Disorder and Treatment (6 papers), Stress Responses and Cortisol (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Belmaker Rh is often cited by papers focused on Bipolar Disorder and Treatment (6 papers), Stress Responses and Cortisol (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Belmaker Rh collaborates with scholars based in Israel, United States and Palestinian Territory. Belmaker Rh's co-authors include Richard P. Ebstein, Rajiv Tandon, W. W. Fleischhacker, Jean‐Pierre Olié, Dan J. Stein, Ahmed Okasha, Juan J López-Ibor, Hans‐Juergen Moeller, Bruce Singh and Wagner F. Gattaz and has published in prestigious journals such as American Journal of Psychiatry, Molecular Psychiatry and Schizophrenia Research.

In The Last Decade

Belmaker Rh

39 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belmaker Rh Israel 13 354 127 113 90 87 40 712
Thomas Walch Austria 14 406 1.1× 102 0.8× 57 0.5× 83 0.9× 52 0.6× 15 781
Y. Kasahara Japan 16 206 0.6× 172 1.4× 116 1.0× 29 0.3× 59 0.7× 37 762
Adolfo Pazzagli Italy 15 314 0.9× 232 1.8× 85 0.8× 163 1.8× 66 0.8× 34 708
R Gruen United States 14 315 0.9× 202 1.6× 60 0.5× 46 0.5× 92 1.1× 19 813
Murray Rosenthal United States 15 230 0.6× 101 0.8× 71 0.6× 188 2.1× 124 1.4× 23 899
G. Remington Canada 8 468 1.3× 90 0.7× 184 1.6× 78 0.9× 96 1.1× 8 712
Elizabeth Zachariah United Kingdom 14 283 0.8× 105 0.8× 204 1.8× 50 0.6× 273 3.1× 23 1.1k
Mei‐Chun Hsiao Taiwan 18 203 0.6× 148 1.2× 94 0.8× 129 1.4× 84 1.0× 37 766
Lincoln D. Clark United States 16 165 0.5× 104 0.8× 160 1.4× 140 1.6× 50 0.6× 39 892
Joel Kotin United States 10 330 0.9× 171 1.3× 187 1.7× 185 2.1× 57 0.7× 17 744

Countries citing papers authored by Belmaker Rh

Since Specialization
Citations

This map shows the geographic impact of Belmaker Rh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belmaker Rh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belmaker Rh more than expected).

Fields of papers citing papers by Belmaker Rh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belmaker Rh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belmaker Rh. The network helps show where Belmaker Rh may publish in the future.

Co-authorship network of co-authors of Belmaker Rh

This figure shows the co-authorship network connecting the top 25 collaborators of Belmaker Rh. A scholar is included among the top collaborators of Belmaker Rh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belmaker Rh. Belmaker Rh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rh, Belmaker, Yuly Bersudsky, & Galila Agam. (2012). Individual differences and evidence-based psychopharmacology. BMC Medicine. 10(1). 110–110. 9 indexed citations
2.
Mischoulon, David, Marlene P. Freeman, Yutaka Matsuoka, et al.. (2012). Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Molecular Psychiatry. 17(12). 1161–1163. 116 indexed citations
3.
Tandon, Rajiv, Belmaker Rh, Wagner F. Gattaz, et al.. (2008). World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research. 100(1-3). 20–38. 198 indexed citations
4.
Nemets, Boris, et al.. (2008). PREVALENCE OF HISTORY OF CHILDHOOD SEXUAL ABUSE IN CONSECUTIVE HOSPITAL ADMISSIONS OF WOMENWITH PSYCHOTIC DIAGNOSIS. Schizophrenia Research. 102(1-3). 161–161. 1 indexed citations
5.
Bersudsky, Yuly, et al.. (2002). Prophylactic effects of phenytoin in bipolar illness: A controlled study. European Neuropsychopharmacology. 12. 179–179. 1 indexed citations
6.
Einat, Haim & Belmaker Rh. (2001). [Animal models of psychiatric diseases: possibilities, limitations, examples and demonstration of use].. PubMed. 140(6). 458–63, 568. 2 indexed citations
7.
Elbedour, Salman, Ahmad M. Baker, Nadera Shalhoub‐Kevorkian, Michael R. Irwin, & Belmaker Rh. (1999). Psychological responses in family members after the Hebron massacre. Depression and Anxiety. 9(1). 27–31. 2 indexed citations
8.
Ebstein, Richard P. & Belmaker Rh. (1997). Saga of an adventure gene: Novelty Seeking, substance abuse and the dopamine D4 receptor (D4DR) exon III repeat polymorphism. Molecular Psychiatry. 2(5). 381–384. 68 indexed citations
9.
Kotler, Moshe, et al.. (1997). P.2.078 Clotiapine: Another forgotten treasure in psychiatry?. European Neuropsychopharmacology. 7. S217–S217.
10.
Zohar, Joseph, Zecharya Shemesh, & Belmaker Rh. (1986). Utility of neuroleptic blood levels in the treatment of acute psychosis.. PubMed. 47(12). 600–3. 1 indexed citations
11.
Rh, Belmaker, et al.. (1984). Rorschach Markers in Euthymic Manic-Depressive Illness. Neuropsychobiology. 12(2-3). 96–100. 12 indexed citations
12.
Rh, Belmaker, et al.. (1984). [Carbamazepine in the treatment of affective disorders].. PubMed. 107(7-8). 176–80. 10 indexed citations
13.
Eisenberg, J, et al.. (1984). A controlled trial of vasopressin treatment of childhood learning disorder.. PubMed. 19(7). 1137–41. 10 indexed citations
14.
Zohar, Joseph, et al.. (1983). The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.. PubMed. 18(5). 553–60. 10 indexed citations
15.
Lerer, Bernard, et al.. (1983). Effect of vasopressin on memory following electroconvulsive therapy.. PubMed. 18(7). 821–4. 35 indexed citations
16.
Rh, Belmaker, et al.. (1983). [The role of norepinephrine in schizophrenia].. PubMed. 104(9). 398–401. 2 indexed citations
17.
Biederman, Joseph, Joseph Lerner, & Belmaker Rh. (1979). [Diagnostic problems in manic psychosis].. PubMed. 97(1-2). 28–30. 1 indexed citations
18.
Zohar, Joseph, Joseph Biederman, Ranan Rimón, Richard P. Ebstein, & Belmaker Rh. (1978). Clinical correlates of CSF cyclic nucleotides in schizophrenia. American Journal of Psychiatry. 135(2). 253–255. 8 indexed citations
19.
Rimón, Ranan, Belmaker Rh, & Richard P. Ebstein. (1977). Psychosomatic aspects of juvenile rheumatoid arthritis. Scandinavian Journal of Rheumatology. 6(1). 1–10. 28 indexed citations
20.
Reches, Avinoam, Richard P. Ebstein, & Belmaker Rh. (1977). d-amphetamine inhibition of platelet MAO from schizophrenic patients.. PubMed. 12(5). 655–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026